These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1578493)

  • 41. Inhibitor(s) of platelet-activating factor (PAF) in human saliva.
    Smal MA; Baldo BA
    Lipids; 1991 Dec; 26(12):1144-7. PubMed ID: 1819702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF).
    Steiner M; Landolfi R; Motola NC; Turcotte JG
    Biochem Biophys Res Commun; 1985 Dec; 133(3):851-5. PubMed ID: 3936503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of structural analogues of PAF-acether on platelet desensitization.
    Keraly CL; Coëffier E; Tencé M; Borrel MC; Benveniste J
    Br J Haematol; 1983 Mar; 53(3):513-21. PubMed ID: 6824590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition by cardiolipins of platelet-activating factor-induced rabbit platelet activation.
    Tsoukatos D; Demopoulos CA; Tselepis AD; Moschidis MC; Donos A; Evangelou A; Benveniste J
    Lipids; 1993 Dec; 28(12):1119-24. PubMed ID: 8121255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [PAF-antagonists with lipid structure. 6. Alkylpropandiol lipids with acyl- and ether- structures at the C-3 position and heterocyclic head groups; synthesis, characterization and structure-activity relationship].
    Kertscher HP
    Pharmazie; 1997 Sep; 52(9):672-5. PubMed ID: 9411454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
    Carceller E; Merlos M; Giral M; Balsa D; Almansa C; Bartrolí J; García-Rafanell J; Forn J
    J Med Chem; 1994 Aug; 37(17):2697-703. PubMed ID: 7914928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G; Alloatti G; Mariano F; Lupia E; Lucchina PG; Musso E; Emanuelli G; Camussi G
    Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation.
    Zhang M; Zhang LZ; Lu JS
    Zhongguo Yao Li Xue Bao; 1995 May; 16(3):209-12. PubMed ID: 7660812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
    Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
    J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor.
    Tokumura A; Yoshida J; Maruyama T; Fukuzawa K; Tsukatani H
    Thromb Res; 1987 Apr; 46(1):51-63. PubMed ID: 3647677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
    Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
    Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
    [No Abstract]   [Full Text] [Related]  

  • 52. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    J Lipid Mediat; 1991; 3(2):225-37. PubMed ID: 1797154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism.
    Le Blanc K; Samuelsson J; Brohult J; Berg A; Palmblad J
    Biochem Pharmacol; 1995 May; 49(11):1577-82. PubMed ID: 7786298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mepyramine inhibits platelet activating factor-induced rabbit platelet aggregation: role of intracellular histamine.
    Zeng S; Guo ZG
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):155-8. PubMed ID: 10072970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
    Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
    J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
    Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
    Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histamine release from rabbit platelets by platelet-activating factor (PAF).
    Nakahodo K; Saitoh S; Nakamura M; Kosugi T
    Arerugi; 1994 Mar; 43(3):501-10. PubMed ID: 7515227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr.
    Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
    Eur J Pharmacol; 1992 Jul; 218(1):129-35. PubMed ID: 1327822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.
    Coëffier E; Borrel MC; Lefort J; Chignard M; Broquet C; Heymans F; Godfroid JJ; Vargaftig BB
    Eur J Pharmacol; 1986 Nov; 131(2-3):179-88. PubMed ID: 3816952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.